HCV-RNA (TMA)

sustained responder to therapy

sustained non-responder

No.

total

No.

total

At week 24

negative

41/49 (83.7%)

41/54

(75.9%)

8/49 (16.3%)

13/54

(24.07%)

positive

0/5

5/5 (100%)

At week 48

negative

41/47 (87.2%)

41/54

(75.9%)

6/47 (12.8%)

13/54

(24.07%)

positive

0/7

7/7 (100%)

At week 72

negative

40/40 (100%)

40/49

(86.9%)

0/40

6/46

(13.04%)

positive

0/6

6/6 (100%)